C4XD.L Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 18:38):

Stats
Tagesvolumen	27.55M
Durchschnittsvolumen	1.20M
Marktkapitalisierung	30.27M
EPS	£0.0706 ( Q2 \| 2024-01-31 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	3.00 (Sector) 0 (Industry) 0
ATR14	£1.896 (15.80%)

AMYT.L -11.73%

APH.L 0.39%

AVCT.L -0.27%

AZN.L -0.40%

BMK.L 7.59%

BVXP.L -2.16%

C4XD.L 27.32%

CIR.L 0.00%

CLIN.L 0.11%

DEST.L -2.51%

DPH.L 0.05%

EAH.L 3.49%

ERGO.L 0.15%

ETX.L -6.74%

EVG.L 2.25%

FAB.L -1.59%

FARN.L -5.47%

FUM.L 0.27%

GDR.L 1.10%

GNS.L 1.45%

GSK.L -0.52%

HCM.L -0.36%

HEMO.L -2.66%

HIK.L -0.58%

IMM.L -1.15%

INDV.L 0.28%

IXI.L -5.25%

MTPH.L 1 794.74%

MXCT.L -2.17%

N4P.L -4.71%

NCYT.L -2.42%

NFX.L -5.00%

OBD.L 0.92%

OKYO.L -24.32%

ONC.L 0.45%

OPTI.L -3.75%

OVB.L -2.22%

OXB.L 2.58%

PRM.L -4.82%

PRTC.L 0.22%

PYC.L -6.25%

REDX.L 31.58%

RENE.L -2.17%

SAR.L 7.00%

SCLP.L -1.86%

SLN.L -0.93%

SNG.L 3.48%

STX.L 2.70%

TILS.L 8.33%

TRX.L -1.15%

VAL.L 0.00%

VEC.L 0.00%

Volumen Korrelation

Lang: -0.06 (neutral)

Kurz: 0.61 (weak)

Signal:(57.209) Neutral

C4X Discovery Holdings Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

C4X Discovery Holdings Korrelation - Währung/Rohstoff

0.39
( neutral )

0.24
( neutral )

0.40
( neutral )

0.38
( neutral )

-0.30
( neutral )

-0.43
( neutral )

C4X Discovery Holdings Finanzdaten

Annual	2023
Umsatz:	£1.71M
Bruttogewinn:	£1.67M (97.78 %)
EPS:	£-0.0442

FY	2023
Umsatz:	£1.71M
Bruttogewinn:	£1.67M (97.78 %)
EPS:	£-0.0442

FY	2022
Umsatz:	£2.70M
Bruttogewinn:	£2.57M (95.18 %)
EPS:	£-0.0357

FY	2021
Umsatz:	£5.64M
Bruttogewinn:	£5.55M (98.40 %)
EPS:	£-0.0400

Financial Reports:

No articles found.

C4X Discovery Holdings Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

C4X Discovery Holdings

C4X Discovery Holdings plc operates as a drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality. The company's product pipeline includes Orexin-1, a receptor antagonist for the treatment of addictive disorders; NRF-2 activator to treat various inflammatory diseases; IL-17A inhibitor for inflammation and autoimmune diseases; a4ß7 integrin inhibitors for the treatment of inflammatory bowel disease; and MALT-1 inhibitors to treat hematological cancer. It has partnerships with Sanofi, GEN-COVID, LifeArc, Indivior PLC, Phoremost, AstraZeneca UK Limited, and Evotec SE. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was incorporated in 2007 and is based in Manchester, the United Kingdom.